Patent application number | Description | Published |
20100052858 | Method and system for performing affinity transactions - There is provided a physical token for use in a defined venue with a server having communication with the physical token. The physical token may comprise an identification data and a transmitter configured to transmit the identification data. The physical token is configured to transmit the identification data to the server to cause the server to initiate a sensory interaction with a user possessing the physical token. The sensory interaction may comprise a character in the defined venue interacting with the user possessing the physical token. The sensory interaction may also comprise a display screen in the defined venue displaying information to the user possessing the physical token. The sensory interaction may further comprise an audio speaker in the defined venue announcing information to the user possessing the physical token. The physical token may represent an affinity comprising an experience, entitlement, or characteristic of the user possessing the physical token. | 03-04-2010 |
20100052916 | IDENTIFICATION BAND WITH SECURED ASSOCIATION TO WEARER - There is provided an identification band configured to be associated with a wearer. The identification band comprises a first band transceiver configured to receive a first profile of the wearer; a memory configured to store the first profile; and a sentinel circuit configured to detect removal of the identification band from the wearer and to detect reattachment of the identification band; wherein the identification band configured to dissociate from the wearer if the sentinel circuit detects removal of the identification band from the wearer, the identification band further configured to re-associate to the wearer if the sentinel circuit detects reattachment of the identification band. The identification band may dissociate from the wearer by invalidating the first profile stored in the memory, and the identification band may re-associate to the wearer upon receiving a second profile that uniquely identifies the first profile. | 03-04-2010 |
20120154125 | Method and System for Performing Affinity Transactions - There is provided a physical token for use in a defined venue with a server having communication with the physical token. The physical token may comprise an identification data and a transmitter configured to transmit the identification data. The physical token is configured to transmit the identification data to the server to cause the server to initiate a sensory interaction with a user possessing the physical token. The sensory interaction may comprise a character in the defined venue interacting with the user possessing the physical token. The sensory interaction may also comprise a display screen in the defined venue displaying information to the user possessing the physical token. The sensory interaction may further comprise an audio speaker in the defined venue announcing information to the user possessing the physical token. The physical token may represent an affinity comprising an experience, entitlement, or characteristic of the user possessing the physical token, | 06-21-2012 |
20130176114 | Method and System for Performing Affinity Transactions - There is provided a physical token for use in a defined venue with a server having communication with the physical token. The physical token may comprise an identification data and a transmitter configured to transmit the identification data. The physical token is configured to transmit the identification data to the server to cause the server to initiate a sensory interaction with a user possessing the physical token. The sensory interaction may comprise a character in the defined venue interacting with the user possessing the physical token. The sensory interaction may also comprise a display screen in the defined venue displaying information to the user possessing the physical token. The sensory interaction may further comprise an audio speaker in the defined venue announcing information to the user possessing the physical token. The physical token may represent an affinity comprising an experience, entitlement, or characteristic of the user possessing the physical token. | 07-11-2013 |
Patent application number | Description | Published |
20090075891 | Methods and dressings for sealing internal injuries - Disclosed are solid and frozen haemostatic materials and dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings. | 03-19-2009 |
20120148658 | SOLID DRESSING FOR TREATING WOUNDED TISSUE - Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of fibrinogen and a fibrinogen activator, wherein the fibrinogen is present in an amount between 3.0 mg/cm | 06-14-2012 |
20120148659 | SOLID DRESSING FOR TREATING WOUNDED TISSUE - Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and a fibrinogen activator, wherein the haemostatic layer(s) is cast or formed from a single aqueous solution containing the fibrinogen component and the fibrinogen activator. Also disclosed are methods for treating wounded tissue using these dressings and frozen compositions useful for preparing the haemostatic layer(s) of these dressings. | 06-14-2012 |
20120150087 | SOLID DRESSING FOR TREATING WOUNDED TISSUE - Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and thrombin, wherein the thrombin is present in an amount between 0.250 Units/mg of fibrinogen component and 0.062 Units/mg of fibrinogen component. Also disclosed are methods for treating wounded tissue. | 06-14-2012 |
20120321692 | Methods and Dressings for Sealing Internal Injuries - Disclosed are solid and frozen haemostatic materials and dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings. | 12-20-2012 |
20130287837 | SOLID DRESSING FOR TREATING WOUNDED TISSUE - Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and a fibrinogen activator, wherein the haemostatic layer(s) is cast or formed from a single aqueous solution containing the fibrinogen component and the fibrinogen activator. Also disclosed are methods for treating wounded tissue using these dressings and frozen compositions useful for preparing the haemostatic layer(s) of these dressings. | 10-31-2013 |
20150118284 | SOLID DRESSING FOR TREATING WOUNDED TISSUE - Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and thrombin, wherein the thrombin is present in an amount between 0.250 Units/mg of fibrinogen component and 0.062 Units/mg of fibrinogen component. Also disclosed are methods for treating wounded tissue. | 04-30-2015 |
Patent application number | Description | Published |
20090202039 | Methods for Sterilizing Biological Materials Containing Non-Aqueous Solvents - Methods are disclosed for sterilizing biological materials to reduce the level of one or more active biological contaminants or pathogens therein, such as viruses, bacteria (including inter- and intracellular bacteria, such as mycoplasmas, ureaplasmas, nanobacteria, | 08-13-2009 |
20110091353 | Methods for Sterilizing Tissue - Methods are disclosed for sterilizing tissue to reduce the level of one or more active biological contaminants or pathogens therein, such as viruses, bacteria, (including inter- and intracellular bacteria, such as mycoplasmas, ureaplasmas, nanobacteria, chlamydia, rickettsias), yeasts, molds, fungi, prions or similar agents responsible, alone or in combination, for TSEs and/or single or multicellular parasites. The methods involve sterilizing one or more tissues with irradiation. | 04-21-2011 |